Biechele Royce Advisors Trims Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Biechele Royce Advisors cut its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 1.0% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,676 shares of the company’s stock after selling 90 shares during the quarter. Procter & Gamble makes up approximately 0.5% of Biechele Royce Advisors’ holdings, making the stock its 28th largest holding. Biechele Royce Advisors’ holdings in Procter & Gamble were worth $1,503,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. PCG Wealth Advisors LLC acquired a new stake in shares of Procter & Gamble during the 1st quarter worth approximately $258,000. Massachusetts Wealth Management increased its position in Procter & Gamble by 0.9% in the first quarter. Massachusetts Wealth Management now owns 10,991 shares of the company’s stock worth $1,783,000 after buying an additional 100 shares during the period. Kovack Advisors Inc. lifted its stake in Procter & Gamble by 21.2% in the first quarter. Kovack Advisors Inc. now owns 20,215 shares of the company’s stock valued at $3,280,000 after buying an additional 3,542 shares during the last quarter. First Trust Direct Indexing L.P. boosted its holdings in shares of Procter & Gamble by 11.2% during the first quarter. First Trust Direct Indexing L.P. now owns 55,917 shares of the company’s stock valued at $9,073,000 after acquiring an additional 5,653 shares during the period. Finally, Accel Wealth Management grew its position in shares of Procter & Gamble by 929.0% during the first quarter. Accel Wealth Management now owns 31,015 shares of the company’s stock worth $5,032,000 after acquiring an additional 28,001 shares during the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Stock Performance

Shares of NYSE PG traded down $0.08 during trading hours on Friday, hitting $165.10. 5,455,095 shares of the stock were exchanged, compared to its average volume of 6,645,703. The firm has a market capitalization of $388.82 billion, a P/E ratio of 28.47, a P/E/G ratio of 3.59 and a beta of 0.41. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The company’s 50 day moving average is $171.62 and its 200 day moving average is $167.91.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company’s quarterly revenue was down .6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.83 earnings per share. On average, research analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.44%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Insider Activity

In other news, CEO Jon R. Moeller sold 72,174 shares of the stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $171.01, for a total value of $12,342,475.74. Following the completion of the transaction, the chief executive officer now directly owns 263,158 shares of the company’s stock, valued at approximately $45,002,649.58. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Procter & Gamble news, insider Susan Street Whaley sold 450 shares of the business’s stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $76,149.00. Following the transaction, the insider now owns 13,072 shares of the company’s stock, valued at approximately $2,212,043.84. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jon R. Moeller sold 72,174 shares of Procter & Gamble stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $171.01, for a total value of $12,342,475.74. Following the completion of the transaction, the chief executive officer now directly owns 263,158 shares of the company’s stock, valued at $45,002,649.58. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 389,144 shares of company stock worth $66,184,385. 0.18% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have weighed in on PG shares. Piper Sandler initiated coverage on Procter & Gamble in a research note on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a report on Monday, September 30th. DA Davidson raised their target price on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research note on Monday, October 21st. Jefferies Financial Group lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and reduced their price target for the stock from $182.00 to $175.00 in a research note on Wednesday, July 24th. Finally, Morgan Stanley raised their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $177.00.

Read Our Latest Analysis on PG

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.